“Veterinarians should use their specialised training to review their patients’ medical histories and determine‚ in consultation with pet owners‚ whether a product in the isoxazoline class is appropriate for the pet.
“The FDA continues to monitor adverse drug event reports for these products and encourages pet owners and veterinarians to report adverse drug events.
“You can do this by reporting to the drugs’ manufacturers‚ who are required to report this information to the FDA‚ or by submitting a report directly to the FDA‚” it continued.
Dozens of South Africans are among the many dog owners who have reported that their dogs became ill or died after being given Bravecto‚ a product which claims to provide 12 weeks of protection against fleas and ticks with a single treatment.
Cheryl Wigmore‚ of Balgowan‚ KwaZulu-Natal – who blames Bravecto for the death of two of her dogs‚ and has a long list of other South Africans who are adamant that their dogs’ deaths or severe illnesses were caused by Bravecto – welcomed the FDA alert.